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Abstract
Background: Despite marked benefits in many heart failure patients, a considerable proportion of patients treated
with cardiac resynchronization therapy (CRT) fail to respond appropriately. Recently, a “U-shaped” (type II) wall motion
pattern identified by cardiovascular magnetic resonance (CMR) has been associated with improved CRT response
compared to a homogenous (type I) wall motion pattern. There is also evidence that a left ventricular (LV) lead
localized to the latest contracting LV site predicts superior response, compared to an LV lead localized remotely
from the latest contracting LV site.
Methods: We prospectively evaluated patients undergoing CRT with pre-procedural CMR to determine the presence
of type I and type II wall motion patterns and pre-procedural echocardiography to determine end systolic volume (ESV).
We assessed the final LV lead position on post-procedural fluoroscopic images to determine whether the lead
was positioned concordant to or remote from the latest contracting LV site. CRT response was defined as a ≥ 15 %
reduction in ESV on a 6 month follow-up echocardiogram.
Results: The study included 33 patients meeting conventional indications for CRT with a mean New York Heart
Association class of 2.8 ± 0.4 and mean LV ejection fraction of 28 ± 9 %. Overall, 55 % of patients were echocardiographic
responders by ESV criteria. Patients with both a type II pattern and an LV lead concordant to the latest contracting site
(T2CL) had a response rate of 92 %, compared to a response rate of 33 % for those without T2CL (p = 0.003). T2CL
was the only independent predictor of response on multivariate analysis (odds ratio 18, 95 % confidence interval
1.6-206; p = 0.018). T2CL resulted in significant incremental improvement in prediction of echocardiographic response
(increase in the area under the receiver operator curve from 0.69 to 0.84; p = 0.038).
Conclusions: The presence of a type II wall motion pattern on CMR and a concordant LV lead predicts superior CRT
response. Improving patient selection by evaluating wall motion pattern and targeting LV lead placement may
ultimately improve the response rate to CRT.
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Background
Cardiac resynchronization therapy (CRT) improves mor-
bidity and mortality in many heart failure patients, yet 1
in 3 patients fail to respond [1]. The pursuit of echocar-
diographic measures of myocardial dyssynchrony to refine
patient selection has been disappointing [2], and current
CRT selection criteria include only functional class, left
ventricular (LV) ejection fraction (EF), QRS duration, and
QRS morphology [3]. In general, favorable electrocardio-
graphic criteria associated with improved response are a
left bundle branch block (LBBB) morphology and a QRS
duration greater than 150 ms [4–6]. To better refine these
clinical criteria, an evolving understanding of the electrical
and mechanical substrate within the myocardium is
needed [7–15].
A “U-shaped” (type II) LV wall motion pattern, suggest-
ive of electrical conduction block, can be demonstrated
with cardiovascular magnetic resonance (CMR), and has
been associated with a superior CRT response com-
pared to a more homogenous (type I) pattern [12].
Other studies have demonstrated that targeting the LV
pacing lead to the latest site of LV contraction improves
patient response [8–11]. Both strain echocardiography
and CMR can identify the latest contracting LV site and
areas of non-viable scar unsuitable for pacing [8–11, 16, 17].
CRT guided by such methods has yielded results super-
ior to conventional implantation in randomized controlled
trials [8, 9].
To date, no studies have evaluated LV lead location
relative to specific patterns of LV wall motion in patients
undergoing CRT. We investigated how CMR-derived
wall motion patterns interact with LV lead location to
influence response to CRT. We hypothesized that pa-
tients with both a type II wall motion pattern and an LV
lead located at the latest contracting site would have a
superior CRT response compared to those with only one
or neither of these characteristics.
Methods
Patient selection
From 2003 to 2013, we prospectively recruited consecutive
patients being referred for CRT. All patients had systolic
heart failure (EF ≤ 35 % by transthoracic echocardiography),
QRS duration > 120 ms, and New York Heart Association
functional class II or III symptoms despite optimal medical
therapy. Patients were enrolled only if they would be able to
follow up 6 months after the CRT procedure and if they had
no known contraindications to CMR. The Emory University
institutional review board approved the study and all pa-
tients gave written informed consent prior to enrollment.
Electrocardiogram classification
A favorable electrocardiogram (ECG) was defined as true
LBBB morphology and QRS duration > 150 ms. True
LBBB morphology was classified as a QS or rS complex
in V1 and/or V2; monophasic R wave in leads I, aVL,
V5, and V6; and mid QRS notching or slurring in at
least two of the following leads: I, aVL, V1, V2, V5, or
V6. Non-favorable ECGs were those that demonstrated
an atypical LBBB, an intraventricular conduction delay
not satisfying criteria for true LBBB, or a QRS dur-
ation < 150 ms. Given that significant intraventricular
conduction delay may exist in the presence of right
bundle branch block [14, 18], patients with bifascicular
block patterns were included in the analysis, but those
with isolated right bundle branch blocks were excluded.
Transthoracic echocardiography
Patients underwent two-dimensional transthoracic echo-
cardiography at baseline and at 6 month follow-up. The
echocardiographic studies were performed on a General
Electric Vivid 7 (Milwaukee, Wisconsin). LV end-systolic
volume (ESV), end-diastolic volume, and EF were assessed
by Simpson’s modified biplane method of discs using
the apical four-chamber and apical two-chamber views.
All echocardiograms were reviewed by a board-certified
reader blinded to baseline and follow-up status.
Cardiovascular magnetic resonance
CMR was performed on a 1.5 T Siemens Avanto scanner
(Erlangen, Germany) with a 5-element phased array coil
and ECG triggering. Steady-state free precession (SSFP)
short-axis images were acquired parallel to the mitral valve
plane to cover the entire length of the LV (8 mm slices
with no slice gap). Two-, three-, and four-chamber cine
images were also acquired. Late gadolinium enhancement
(LGE) CMR was performed with a phase-sensitive in-
version recovery sequence 10–15 minutes after the ad-
ministration of 0.1 mmol/kg MultiHance (gadobenate
dimeglumine; Bracco Diagnostics, Singen, Germany). LGE
images were acquired in the basal, mid, and apical short
axis, as well as the two-, three-, and four-chamber views.
Significant scar was defined as enhancement in > 15 % of
LV myocardium [19].
Left ventricular wall motion analysis
Endocardial borders were traced on each frame of the
short-axis cine images and radial displacement curves
were generated as previously described [20]. Briefly, radial
displacement curves were generated by measuring the ra-
dial distance of the endocardial contour relative to the LV
centroid at 100 circumferentially spaced points for each
slice. To account for translation of the LV over the cardiac
cycle, the LV centroid was determined from the location
of the mitral valve annulus and apex on every frame in the
two and four-chamber views. Regional wall motion delay
times were determined by cross-correlating each radial
displacement curve to a patient-specific reference curve
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and recording the delay time for peak correlation. Re-
gional radial displacement curves were compared visually
to long and short axis cines for regional myocardial thick-
ening and LGE images to determine akinetic segments
with passive movement, which were excluded from wall
motion analysis.
Regional wall motion delays were determined through-
out the LV (excluding the apex) and then mapped to a
modified American Heart Association 17-segment model
[21] (Fig. 1). LV wall motion patterns were categorized
as type I if the wave front proceeded homogenously from
the septum to the LV free wall (no adjacent early and
late segments) and type II if the wave front was heteroge-
neous with evidence of an inferred line of block (adjacent
early and late segments; Fig. 2). Septal flash was identified
by rapid inward and outward motion during isovolumic
contraction involving at least one of the septal segments.
Isovolumic contraction time was characterized as the inter-
val from the onset of LV contraction to aortic valve opening
as visualized on long-axis cine SSFP images and confirmed
by radial displacement curve analysis. In areas of septal
flash, the time to peak radial displacement was defined as
the initial radial displacement, rather than a subsequent
peak likely representing rebound.
Identification of the latest contracting site
The number of discrete myocardial sites sampled per
segment ranged from 50–100, depending on the number
of short axis slices obtained (i.e. the LV length) and the
apical versus mid or basal position. The latest contract-
ing site was defined as latest single site to reach max-
imum radial displacement. The segment containing this
site was defined as the latest contracting segment.
Coronary venography and device implantation
The implanting electrophysiologist had no knowledge
of the CMR derived wall motion patterns prior to
implantation. All CRT devices were implanted using stand-
ard procedure. Briefly, central venous access was gained via
either the subclavian vein or cephalic vein cut-down. Bi-
plane balloon catheter coronary venography defined coron-
ary venous anatomy in the 30° right-anterior-oblique and
30° left-anterior-oblique views. A suitable anterolateral, lat-
eral, or posterolateral coronary vein was selected based
solely on anatomic characteristics; the CMR data was not
used to guide this decision.
Left ventricular lead localization
Final LV lead position was determined by biplane fluor-
oscopy and comparison to baseline venous anatomy by
coronary venography. The right anterior oblique image
defined long-axis position, while the left anterior oblique
image defined short-axis position (Fig. 3). Using these
images, LV lead position was mapped to the modified
American Heart Association 17-segment model. As de-
scribed in previous studies [8, 9], final LV lead placement
was considered concordant if placed in a viable segment
within 1 segment of the latest contracting segment, and
remote if placed more than 1 segment from the latest con-
tracting segment. If the LV lead was placed in a non-viable
segment with > 50 % transmural LGE, lead position was
considered remote.
Study outcome
The primary outcome was positive echocardiographic
response to CRT, defined as reverse LV remodeling with
a reduction in ESV by ≥ 15 % at 6 months. We compared
response in patients with both a type II pattern and con-
cordant lead (T2CL) to those without both of these find-
ings (i.e. type I pattern and/or remote leads).
Statistical analysis
Statistical analysis was performed with SPSS version 20
(Chicago, Illinois) and SAS version 9.3 (Cary, North
Fig. 1 CMR processing and wall motion pattern analysis. Endocardial contours were traced on short-axis cine images (a; red circle) and the distance to
the centroid computed for each site (b). Each color curve represents a corresponding colored line from a; 100 sites were sampled per slice, however,
only 12 are shown here for graphical simplicity. Each regional radial displacement curve is compared by cross-correlation (sliding in time) to a patient-
specific reference (b; yellow dotted line) to determine the mechanical delay time. Delay times are mapped to a modified American Heart Association
17-segment model (c). Note the early motion in the septal segments in b, shown in red in c, represents the septal flash
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Carolina). Dichotomous variables were expressed as num-
bers and percentages, while continuous variables were
expressed as mean ± standard deviation. Fisher’s Exact test
was used to compare categorical variables. Continuous
variables were compared by the Student’s t-test (normal
distribution) or the Mann–Whitney U test (non-normal
distribution). Predictors of CRT response were analyzed
by univariate binary logistic regression analysis. Inde-
pendent predictors were analyzed by multivariate binary
logistic regression analysis in a model including trad-
itional variables associated with CRT response (favorable
ECG and non-ischemic cardiomyopathy, NICM). A 1000
sample bootstrapping analysis was done to assess internal
validity of the multivariate model using SPSS. In an ex-
ploratory analysis, novel imaging variables (presence of
significant scar, maximum opposite wall delay, and septal
flash on CMR) were added to the multivariate model to
evaluate for an additional effect. The incremental benefit
of T2CL was assessed by improvement in the area under
the receiver-operating curve (AUC) before and after its
addition to the multivariate model. Cohen’s kappa coeffi-
cient was used to test the interobserver variability of CMR
wall motion pattern and LV lead position. Statistical sig-




Thirty-three patients were included in our analysis. Thir-
teen patients (39 %) were determined to have a type I
(homogeneous) wall motion pattern, while 20 (61 %) had
a type II (U-shaped) wall motion pattern. Two of the pa-
tients had bifascicular block (6 %); both of these patients
had type I rather than type II contraction patterns. Type
II patterns were present in 85 % of patients with favorable
ECGs and 45 % of patients with non-favorable ECGs. Of
the 20 patients with a type II pattern, 15 (75 %) had an in-
ferior line of block and 5 (25 %) had an anterior line of
block. The latest contracting segment was adjacent to the
line of block in 19 of the 20 patients (95 %).
Among the 33 patients in the cohort, the LV lead was
concordant in 18 patients (54 %) and remote in 15 pa-
tients (46 %). True concordance, with the presence of
the LV lead directly within the latest contracting segment,
was observed in one patient; the remaining 17 (94 %) had
the LV lead adjacent to the latest contracting segment. In
14 of these patients (82 %), the lead was in the next latest
contracting segment. A full set of baseline characteristics
for all patients and then grouped by echocardiographic re-
sponse is shown in Table 1. Relevant baseline findings
grouped by wall motion pattern is shown in Table 2.
Patients with type II patterns were more likely to have a
favorable ECG, less significant scar on LGE, septal flash,
and longer maximum opposing wall delays compared to
those with type I patterns.
Response: baseline clinical and imaging variables
The median time from CRT implantation to follow-up
echocardiogram was 198 days (interquartile range 184 to
227 days). The overall echocardiographic response rate
was 55 %. Responders were more likely to have NICM, a
type II pattern, a concordant LV lead, and T2CL, as shown
in Table 1. Otherwise, there were no significant differences
between responders and non-responders.
Fig. 2 Type I and type II wall motion patterns. Modified American Heart
Association models demonstrating (a) a type I wall motion pattern,
with dotted lines indicating homogenous wave fronts anteriorly and
inferiorly towards the lateral wall, and (b) a type II wall motion pattern,
with an inferior line of block (green line) and dotted line indicating an
anteriorly directed wave front and late inferior wall motion
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Response: wall motion patterns and lead position
The response rate for T2CL patients was significantly
higher than non-T2CL patients, with intermediate response
rates for all patients with a type II pattern regardless of lead
location and all patients with a concordant LV lead position
regardless of wall motion pattern (Table 3). Overall, all type
I pattern patients had a 31 % response rate and all remote
LV lead patients had a 33 % response rate.
Response: ECG patterns
The response rate for patients with favorable ECGs was
69 %, compared to 45 % for those with non-favorable
ECGs (p = 0.28). In those with non-favorable ECGs, the
presence of T2CL was associated with significantly greater
likelihood of response compared to those without T2CL
(86 % versus 23 %, p = 0.017).
Response: LGE and NICM
Thirty patients (91 %) underwent LGE imaging (3
were excluded due to severe renal insufficiency or pa-
tient discomfort necessitating early exam termination)
and 8 patients (24 %) had significant scar (6 with a
type I pattern and 2 with a type II pattern). The re-
sponse rate in patients with significant scar was 25 %,
compared to 64 % for those without scar (p = 0.10).
Four patients had an LV lead located in a non-viable
segment, with a 25 % response rate in this group. The
low prevalence of significant LGE precluded statistical
analysis of the effect of T2CL in patients with scar;
however, in the subgroup without significant scar, the
presence of T2CL was associated with significantly
greater response compared to non-T2CL (92 % versus
39 %, p = 0.011).
Fig. 3 Left ventricular lead localization. Biplane venograms (a; right anterior oblique 30°, b: left anterior oblique 30°) and lead localizing still frame
(c; right anterior oblique 30°, left anterior oblique 30° not shown) to map left ventricular pacing lead locations (green ellipse on c) onto the modified
American Heart Association model (d; green circle denotes lead location). Left anterior oblique images were used to determine the circumferential
location while right anterior oblique images were used for longitudinal position
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Predictive modeling and incremental benefit of CMR wall
motion pattern type and lead concordance
On univariate analysis, NICM (odds ratio [OR] 11, 95 %
confidence interval [CI] 1.2-109, p = 0.036), a type II pat-
tern (OR 5.3, 95 % CI 1.2-24, p = 0.032), concordant LV
lead location (OR 5.2, 95 % CI 1.2-23, p = 0.030), and
T2CL (OR 22, 95 % CI 2.3-206, p = 0.007) were the only
significant predictors of response. Variables included in
multivariate analysis are shown in Table 4. T2CL was
the only independent predictor of response. The addition
of T2CL to NICM and a favorable ECG resulted in an
increase in AUC for response from 0.69 to 0.84 (p =
0.038). The presence of significant scar was not evalu-
ated in these primary analyses due to the low prevalence
of significant LGE as well as an incomplete data set for
this parameter for the three patients who did not undergo
Table 1 Patient characteristics
All Patients Responders Non-responders P value
N = 33 N = 18 (55 %) N = 15 (45 %)
Age (years) 61 ± 13 61 ± 13 62 ± 12 0.72
Male, n (%) 18 (55) 7 (39) 11 (73) 0.08
NICM, n (%) 26 (79) 17 (94) 9 (60) 0.03
NHYA functional class 2.8 ± 0.4 2.8 ± 0.4 2.8 ± 0.4 0.86
Comorbidities, n (%)
Coronary artery disease 10 (30) 2 (11) 8 (53) 0.02
Diabetes mellitus 9 (27) 5 (28) 4 (27) 0.94
Hypertension 16 (49) 8 (44) 8 (53) 0.73
Dyslipidemia 17 (52) 8 (44) 9 (60) 0.49
Chronic kidney disease 7 (21) 3 (17) 4 (27) 0.67
Atrial fibrillation 7 (21) 4 (22) 3 (20) 0.88
Medications, n (%)
ACE inhibitor/ARB 32 (97) 18 (100) 14 (93) 0.46
Beta-blocker 32 (97) 18(100) 14 (93) 0.46
Aldosterone antagonist 11 (33) 6 (33) 5 (33) 1.00
Diuretic 23 (70) 13 (72) 10 (67) 0.73
Statin 18 (55) 8 (44) 10 (67) 0.30
Clinical variables
Body mass index (kg/m2) 28 ± 5 29 ± 4 28 ± 6 0.89
Resting heart rate (bpm) 73 ± 14 75 ± 17 71 ± 10 0.42
Serum creatinine (mg/dl) 1.06 ± 0.24 1.06 ± 0.24 1.07 ± 0.26 0.90
Favorable ECG patterna, n (%) 13 (39) 9 (50) 4 (27) 0.28
Echocardiographic variables
End-systolic volume (ml) 150 ± 71 143 ± 61 159 ± 84 0.55
Ejection fraction (%) 28 ± 9 27 ± 8 30 ± 9 0.37
Mitral regurgitation grade 1.1 ± 0.8 1.1 ± 0.7 1.1 ± 0.9 0.87
CMR findings
Maximum wall delay (ms) 432 ± 120 455 ± 104 404 ± 135 0.23
Type II pattern, n (%) 20 (61) 14 (78) 6 (40) 0.038
Septal flash, n (%) 27 (82) 17 (94) 10 (67) 0.07
No scar, n (%) 25 (76) 16 (89) 9 (60) 0.10
Concordant CRT lead, n (%) 18 (55) 13 (72) 5 (28) 0.038
Combined type II pattern and concordant CRT lead, n (%) 12 (36) 11 (61) 1 (7) 0.003
aA favorable ECG pattern is indicated by the presence of a true left bundle branch block and a QRS duration > 150 ms
Values are presented as n (%) or mean ± standard deviation. ACE = Angiotensinogen Converting Enzyme; ARB = Angiotensin Receptor Blocker; CMR = Cardiovascular
Magnetic Resonance; CRT = Cardiac Resynchronization Therapy; ECG = Electrocardiogram; LBBB = Left Bundle Branch Block; NYHA = New York Heart Association;
NICM=Non-Ischemic Cardiomyopathy
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LGE imaging. Intermediary analyses with incremental
addition of each covariate into the model along with
T2CL are also shown; results did not deviate signifi-
cantly between these intermediary models and the final
model (Table 5).
Exploratory predictive model
The exploratory addition of maximum opposing wall delay,
presence of septal flash, and presence of significant scar to
the multivariate model did not significantly change results,
with T2CL remaining the only independent predictor of re-
sponse (OR 25, 95 % CI 1.4-453, p = 0.030; 1000 sample
bootstrapping: p = 0.006 for T2CL and p = non-significant
for all others); with an increase in AUC for response from
0.71 to 0.86.
Reproducibility of wall motion patterns and lead position
Two independent observers (GH and JO) reviewed all
33 regional wall motion maps and categorized each as
either type I or type II, demonstrating substantial
agreement (88 %) with a Cohen’s kappa coefficient of
0.75 (p < 0.0001). Two independent observers (GH and
ML) reviewed 15 randomly selected biplane fluoroscopic
images to assess if the LV lead was concordant or remote
to the latest site, demonstrating excellent agreement
(93 %) with a Cohen’s kappa coefficient of 0.87 (p = 0.001).
In both cases, discrepancies were resolved by consensus
review of the two observers to determine the final
classification.
Discussion
We demonstrated that the combination of a type II left
ventricular wall motion pattern and localization of a pacing
lead concordant with the latest contracting LV site inde-
pendently predicted echocardiographic response to CRT. It
is likely that previously identified clinical predictors of re-
sponse, such as NICM and a favorable ECG pattern are
useful due to the relatively high proportion of type II pat-
terns present in these groups. In addition to supporting
this trend, our study showed that type II patterns are also
present in other less favorable groups, for example, nearly
half (45 %) of those with non-favorable ECG. To date,
imaging of dyssynchrony has largely been regarded gen-
erically as a delay in mechanical contraction between
the septal and lateral walls, and prospective utilization
of these criteria for CRT selection has yielded disappoint-
ing results [2]. Recent refinements in imaging methods
aimed at improving CRT response have focused on identi-
fication of specific patterns of LV wall motion or targeting
the site of latest LV contraction [8, 9, 11, 12]. The present
study is the first report on the interaction of lead location
and specific wall motion patterns.
Dichotomous dyssynchrony patterns were first identified
on invasive electrophysiologic mapping of endocardial
electrical activation in patients with left intraventricular
conduction delays and classified as type I and type II
Table 2 CMR wall motion pattern associations
Type I Type II P value
N = 13 (39 %) N = 20 (61 %)
Etiology
NICM, n (%) 8 (62) 18 (90) 0.084
ICM, n (%) 5 (38) 2 (10)
ECG
Favorablea, n (%) 2 (15) 11 (55) 0.032
Non-favorable, n (%) 11 (85) 9 (45)
CMR
Maximum wall delay (ms) 371 ± 117 471 ± 106 0.016
Late gadolinium enhancement
Scar, n (%) 6 (46) 2 (10) 0.035
No scar, n (%) 7 (54) 18 (90)
Septal flash
Present, n (%) 7 (54) 20 (100) 0.002
Absent, n (%) 6 (46) 0 (0)
CRT lead location
Lead concordant, n (%) 6 (46) 12 (60) 0.49
Lead remote, n (%) 7 (54) 8 (40)
aA favorable ECG pattern is indicated by the presence of a true left bundle
branch block and a QRS duration > 150 ms
Values are presented as n (%) or mean ± standard deviation. CMR= Cardiovascular
Magnetic Resonance; CRT = Cardiac Resynchronization Therapy; ECG =
Electrocardiogram; ICM = Ischemic Cardiomyopathy;
NICM = Non-Ischemic Cardiomyopathy
Table 3 Echocardiographic response by wall motion pattern and lead location
All Non-T2CL CL Only T2 Only T2CL P valuea
N = 33 N = 21 (64 %) N = 18 (55 %) N = 20 (61 %) N = 12 (36 %)
ΔESV (ml) −24 ± 40 −19 ± 48 −31 ± 40b −30 ± 24c −33 ± 18 0.023
Echocardiographic responderd, n (%) 18 (55) 7 (33) 13 (72) 14 (70) 11 (92) 0.003
aThe p values listed in the table are for the comparison of T2CL versus non-T2CL (type I wall motion pattern and/or a remote left ventricular lead)
bFor a remote lead, regardless of wall motion pattern, ΔESV was −15 ± 40 ml. Compared to those with CL, p = 0.11
cFor a type I wall motion pattern, regardless of lead concordance, ΔESV −15 ± 56 ml. Compared to those with T2, p = 0.019
dEchocardiographic response was defined by a decrease in ESV by ≥ 15 % at 6 month follow-up
CL = Concordant left ventricular lead; ESV = End-Systolic Volume; T2 = Type II wall motion pattern; T2CL = Type II wall motion pattern and a concordant left
ventricular lead
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[22–24]. The two patterns were generally distinguished
by: 1) the degree of trans-septal electrical delay and 2)
the pattern of LV activation relative to the presence
or absence of local conduction block. The type I pat-
tern is characterized by short trans-septal delay and
homogenous slow LV activation towards the lateral
wall, likely related to electromechanical uncoupling
from myopathy instead of specific conduction system
disease (i.e. of the left bundle branch). The type II
pattern is characterized by prolonged trans-septal
delay and an inferoseptal or anteroseptal breakout site
with a corresponding functional line of block resulting in
a “u” or “n” shaped LV activation pattern indicative of a
primary electrical abnormality. “Correction” of the type II
pattern with CRT is associated with mid-term clinical
and echocardiographic improvement, while many patients
with type I patterns fail to significantly respond [7, 15].
Fung et al. demonstrated that type II patients identified by
invasive electrophysiologic mapping had overall improve-
ment in echocardiographic dyssynchrony after CRT, while
type I patients actually had worsening dyssynchrony [7].
Thus, a type II pattern likely represents a discrete line of
conduction block more amenable to electrical resynchro-
nization compared to the diffuse, homogenous conduction
delay of type I.
The discussion above linking mechanical contraction
patterns and electrical conduction patterns depends on
the amount of electro-mechanical (EM) coupling that is
present. We previously conducted a study in patients
undergoing CRT who had a pre-procedural CMR exam.
During the CRT procedure, local intracardiac electrograms
were taken at various sites, and electric times from the
electrograms were correlated to mechanical contraction
times from the CMR studies. We found that electrical and
mechanical delay times were highly correlated in individual
patients, indicating a high level of EM coupling [13].
Recently, Sohal et al. used CMR to define type I and
type II patterns of wall motion in 52 patients planning to
undergo CRT [12]. Utilizing an endocardial displacement
analysis similar to ours, they established the type II pattern
as the only independent predictor of echocardiographic
response at 6 months. Similarly, we demonstrated a higher
likelihood of response in type II patients alone (70 %,
versus 31 % for type I), however, the likelihood of re-
sponse was far superior in type II patients with a con-
cordant LV lead (92 %). Although the type II pattern is
more common in NICM, which is a dependable predictor
of CRT response [25, 26], both our study and that of Sohal
et al. included NICM in multivariate analyses without a
change in the final results. We found the type I pattern to
be more common in patients with ischemic cardiomy-
opathy (ICM) and significant scar, however, only a small
portion of our patients had ICM, precluding a subgroup
analysis of the effects of T2CL within this group. In the
study by Sohal et al., 48 % of the patients had ICM and
type II patients with ICM had more than double the
response rate of type I patients [12]. The relationship
between a type II pattern and response to CRT persisted
after correcting for significant LV scar. Furthermore, an-
other recent study has suggested that the presence of a
septal flash is an important predictor of CRT response in
addition to scar absence [27]. Our exploratory analysis
Table 4 Predictors of echocardiographic response
Univariate Multivariate
Variable Odds ratio 95 % confidence
interval
P value for logistic
regression
Odds ratio 95 % confidence
interval
P value for logistic
regressiona
NICM 11 1.2-109 0.036 3.1 0.3-37 0.36
Favorable ECGb 2.8 0.6-12 0.18 3.0 0.5-19 0.25
T2CL 22 2.3-206 0.007 18 1.6-206 0.018
aNo significant difference with 1000 sample bootstrapped multivariate logistic regression analysis
(p = 0.012 for T2CL, p = non-significant for all others)
bA favorable ECG pattern is indicated by the presence of a true left bundle branch block and a QRS duration > 150 ms
ECG = Electrocardiogram; NICM = Non-Ischemic Cardiomyopathy; T2CL = Type II wall motion pattern and a concordant left ventricular lead
Table 5 Intermediary multivariate models
Model 1 – T2CL and NICM only Model 2 – T2CL and Favorable ECG only
Variable Odds ratio 95 % confidence
interval
P value for logistic
regression
Odds ratio 95 % confidence
interval
P value for logistic
regressiona
NICM 4.5 0.4-48 0.21 – – –
Favorable ECGa – – – 3.9 0.6-23.7 0.14
T2CL 15 1.5-147 0.02 27 2.6-276 0.006
aA favorable ECG pattern is indicated by the presence of a true left bundle branch block and a QRS duration > 150 ms
ECG = Electrocardiogram; NICM = Non-Ischemic Cardiomyopathy; T2CL = Type II wall motion pattern and a concordant left ventricular lead
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indicates that T2CL predicts CRT response after correc-
tion for both scar presence and septal flash, although limi-
tations of modeling preclude strong conclusions.
Conventional CRT implantation methods targeting the
most anatomically suitable lateral or posterior coronary
vein may contribute to poor response. Often, the latest
contracting LV segment is not located posteriorly or
laterally [14]. Furthermore, implantation of the LV lead
into a segment with significant scar is undesirable [16, 17].
A small study utilizing CMR to target the latest contract-
ing segment without significant scar demonstrated su-
perior echocardiographic response in those with targeted
leads compared to those without [10]. Larger randomized
controlled trials using speckle-tracking echocardiography
to guide LV lead placement to the latest contracting LV
site have also demonstrated superior clinical and echocar-
diographic responses for those in the target arms versus
the control arms [8, 9]. Our findings expand upon these
previous studies and suggest that targeting a particular
substrate (the type II pattern) along with a particular site
(the latest to contract) may yield the highest likelihood of
response.
Currently, the ECG characteristics of true LBBB morph-
ology with a QRS duration > 150 ms are considered the
most important predictors of CRT response [4–6]. Con-
temporary dyssynchrony imaging may be complementary
to ECG findings [28], and patients with less favorable
ECG characteristics may stand to gain the most from im-
aging to determine CRT candidacy and a targeted LV lead
approach [29]. In our study, T2CL was a significantly asso-
ciated with CRT response in patients without favorable
ECG findings. It has been suggested that patients with a
QRS duration < 120–130 ms should not undergo CRT, re-
gardless of the presence of dyssynchrony [30] and patients
without dyssynchrony on imaging may actually be harmed
by CRT [31]. Therefore, a focus on imaging to refine can-
didacy and facilitate optimized interventions may be more
appropriate than ongoing efforts to expand CRT candi-
dacy. AlthoughT2CL was present in a minority of patients
(36 %), the type II pattern was present in the majority
(61 %) and may represent an opportunity to improve re-
sponse by targeting this substrate.
Limitations
This is a small study, which increases the likelihood of
results occurring due to chance. An additional 1000 sample
bootstrapping analysis was performed to ensure internal
validity. Our method utilizes radial displacement of LV
myocardium to characterize regional wall motion, which
does not directly measure mechanical contraction onset or
peaks. Although translational movement is corrected,
passive motion cannot be totally excluded; however, our
method has been validated against electrical activation
patterns obtained by regional intra-operative sampling
[13]. The degree of processing time required for manual
correction of automated edge detection is another limita-
tion of the technique, which is approximately 2 hours per
case. We are currently pursuing and evaluating methods
to increase the speed of processing. Reduction of ESV is a
surrogate imaging end-point [32], however, echocardio-
graphic response has been found to be a superior pre-
dictor of intermediate and long-term hard outcomes in
CRT patients compared to clinical response [33, 34]. The
observational nature of our study did not allow the inves-
tigation of targeting of lead placement based on CMR
findings. As such, our study does not prove that actively
targeting the latest site in type II patients provides super-
ior response; we simply demonstrated the independent
association of these features with a higher likelihood of
response. A prospective randomized interventional trial
of CRT guided by CMR derived wall motion patterns in
a larger group of patients would be the next step in the
validation of this approach.
Conclusion
The combination of a type II U-shaped LV wall motion
pattern identified by CMR and concordant LV lead position
predicts the highest likelihood of response among patients
who meet current CRT implantation criteria. Improving
CRT response rates may ultimately rely on patient selection
by wall motion pattern and targeted LV lead placement,
both of which are facilitated by CMR.
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